Dr. David Bernstein, MD
David E. Bernstein, MD is Vice Chair of Clinical Trials in the Department of Medicine, Chief, Division of Hepatology and Director of the Center for Liver Disease for the Northwell Health System. He is a Professor of Medicine and Professor of Educational Sciences at Hofstra-Northwell Health School of Medicine.
Dr. Bernstein graduated from SUNY-Stony Brook School of Medicine in 1988. He completed his medical residency at Montefiore Medical Center and his fellowship in Gastroenterology and Hepatology at the University of Miami Affiliated Hospitals under the direction of Dr Eugene Schiff.
After completing his Fellowship, Dr. Bernstein joined the faculty of the University of Miami in the Division of Hepatology where he started his career as a clinician, teacher and researcher.
Dr. Bernstein’s main research interest has been in field of liver diseases, with most of his work concentrated on developing new treatments for chronic hepatitis C. Since 1994, he has been involved in designing programs for the treatment of hepatitis C and has been an influential national and international leader in this field. He is the author of over 100 publications, 10 book chapters, and has been the principle investigator in more than 200 clinical trials. His work has been published in such prestigious journals as the New England Journal of Medicine and The Lancet. He regularly is asked to lecture about this topic on Long Island, across the nation and around the globe. His research has led to the development of new medications which are able to cure more than 95% of patients with hepatitis C infection and in the future could lead to the eradication of hepatitis C infection in the United States.
Dr. Bernstein is active in many national and international societies and has held elective office in many of them. He is the current Immediate Past President of the Bockus International Society of Gastroenterology and a former president of the New York Gastrointestinal Society. He served for six years as the American College of Gastroenterology Governor for Long Island. He has served on numerous committees of the American Association for the Study of Liver Diseases and the American College of Gastroenterology. He is also a member of the European Society for the Study of Liver Diseases, the Asia-Pacific Association for the Study of Liver Diseases. He is a fellow of the American Association for the Study of Liver Diseases, the American College of Gastroenterology and the American College of Physicians.
Dr. Bernstein has been involved in shaping public policy and education regarding liver diseases. He serves as a special consultant to the New York State Department of Health. He is also an active lecturer at the Hofstra North Shore LIJ School of Medicine and the course director for the American College of Gastroenterology’s Hepatitis School.
Dr. Bernstein has a reputation as an outstanding clinician and maintains a busy clinical Hepatology practice. He is greatly respected by his fellow physicians and by his patients. Over the years, he has helped improve the quality of life thousands of patients and their families in the area which he serves. Castle-Connelly has recognized him as one the Best Doctors since 2006.
The American Liver Foundation, Greater New York Division is proud to honor Dr. Bernstein this year.
Corporate Partner of the Year
Shannon Campbell has been Vice President and General Manager, Oncology at Bayer HealthCare since 2008. Shannon is responsible for all US commercial activities supporting the oncology business and is a member of the US Pharmaceutical Executive Team, Bayer’s Global Oncology Leadership Team as well as other operational and governance leadership bodies. Shannon has focused on Oncology or Specialty markets for most of her 25+ years in the pharmaceutical industry and has a strong track record of leadership, innovation, alliance relationships & operating experience. She joined Bayer in 2005 to establish an oncology business and lead the US launch for Nexavar. Prior to joining Bayer, Shannon was at Abbott, where she worked primarily to establish an Oncology commercial business unit and later lead the Marketing activities for HUMIRA. Before joining Abbott, Shannon spent more than a decade with the Pharmacia heritage companies (Pharmacia & Upjohn, The Upjohn Company) where she held a variety commercial leadership positions in the United States, Australia, and the United Kingdom. Through her career, Shannon has successfully driven many new product launches on a global basis and maintained a strong focus and commitment to addressing the evolving needs of the healthcare community and patients that she serves. Shannon is an active coach and mentor to many talented individuals and has taken a keen interest in ongoing leadership development. Campbell holds a BS degree in Physical Therapy from Ithaca College and has completed advanced executive training programs at Wharton Business School, IMD, and Harvard Business School. Shannon is married with 2 children and resides in Mendham, New Jersey.
Community Leader of the Year
Don Howard, R.PH.
A pharmacist with over 30 years of pharmacy operating experience and leadership, Don Howard serves as Chief Executive Officer of Envolve Pharmacy Solutions, a wholly-owned subsidiary of Centene Corporation (NYSE: CNC).
In early 2011, Don co-founded AcariaHealth, the specialty pharmacy division of Envolve Pharmacy Solutions. Prior to that, he served as the President, Chief Operating Officer and Co-Founder of CuraScript. After the sale of CuraScript to Express Scripts, Don ran specialty pharmacy operations at Express Scripts and oversaw the successful acquisition and integration of Priority Health. He also brings experience as Vice President of Operations at both Coram Prescription Services and Columbia Pharmacy Solutions.
Don graduated from Creighton University with his Bachelor of Science in Pharmacy.
An active member in the community and industry, Don is on the board of Foundation for Foster Children.